Surgeon; Endocrine Surgeon; Breast Surgeon; Pharmacologist. Current
position: Faculty in the Department of Biomedical Scineces, Faculty of
Health and Caring Professions, ,University of West Attica, Athens,
Greece; Director of her own private medical practice. Titles: Ptychio
of medicine; MSc Minimally Invasive Surgery; MSc Medical Biology; MSc
Biostatistics; PhD Pharmacology; University Diploma in Breast Diseases
University of Strasbourg, France; University Diploma of Laparoscopic
Surgery University of Strasbourg, France. University Diploma of
Endocrine Surgery University Pierre et Marrie Currie Paris, University
Diploma in Targeted Biotherapeis of Inflammatory and Autoimmune
Diseases, University of Montpellier, University Diploma in Inflammatory
Bowel Diseases Medical School University Pierre et Marie Currie Paris.
Postdoctoral research in Pharmacology. She speaks English, German,
Italian, French, Russian, Spanish, Portugues, Dutch. Member of the
Research Committee of EAES. Research and Editorial Activity: Author of
60 publications, 641 citations, reviewer of international journals,
Grant Reviewer, Congress Abstract Reviewer, Executive Editor of
International Journal of Immunotherapy and Cancer Research, member of
Editorial boards of International Journals.
Research Interest: Minimally invasive surgery, endocrine surgery, breast surgery, surgical stress, surgical pharmacology, laparoscopic surgery, robotic surgery, surgical anatomy.
List of Publication:
Yiannakopoulou E Systematic review of the effect of oxidative stress in
minimally invasive surgery in comparison with conventional surgery. Msc
Thesis for the Msc “Minimally invasive surgery, robotic surgery and
telesurgery” Athens 2009
 Yiannakopoulou E Investigation of the role of salicylates in preconditioning Final Report for Postdoctoral Research (IKY Scholarship 15109/07.10.2005) Athens 2007
 Yiannakopoulou E Quality of diagnosis and treatment of arterial hypertension in Greece PhD Thesis Medical School University of Athens, Athens 2003 (3 Citations)
 Yiannakopoulou E Meta-analysis of Randomized Clinical Trials for the evaluation of safety of coxibs Msc Thesis for the Msc Biostatistics Medical School and Department of Mathematics Univesity of Athens, Athens 2004
 Yiannakopoulou E Cellular mechanisms of adaptation in oxidative stress and in heat shock in Saccharomyces cerevisiae: the effect of antioxidants Msc Thesis for the Msc Medical Biology Medical School and Department of Biology University of Athens.
1. Eugenia Ch Yiannakopoulou "BREAST CANCER PHARMACOGENOMICS: CLINICAL IMPLICATIONS FOR PERSONALIZED MEDICINE" for “Omics Aproaches for Breast Cancer” Editor Barth D published by Springer
2. Eugenia Ch Yiannakopoulou " BREAST CANCER THERAPY- CLASSICAL THERAPY, DRUG TARGETS, AND TARGETED THERAPY" for “Omics Aproaches for Breast Cancer” Editor Barth D published by Springer
3. Eugenia Ch Yiannakopoulou , Emmanuel O SALAWU, Debmalya Barh. In silico models of disease In Animal Biotechnology: Models in discovery and Translation: A Verma and A Singh, Edition Elsevier 1st Edition
4. Eugenia Yiannakopoulou “Pharmacogenomics” in OMICS:Advances and applications Barth D, Raja R, Zambare V ( (IN press) Publisher Taylor Francis
5.P.O. Michael, E. Yiannakopoulou, “Trauma of heart and pericardium” in “Trauma of Thorax” P. Michael Litsas Edition Athens 2002, pp 236-297 (in Greek).
6. Τh.Diamantis, A.Kyritsis, D.Koronarchis, A.Kyriakopoulos, M.Kastanakis, E.Yiannakopoulou. “Laparoscopic treatment for gastroesophageal reflux disease. Five year experience” in “Laparoscopic and other invasive techniques in the beginning of 21st century” 2000 Ch Tsigris, Th. Diamantis Litsas Edition Athens (in Greek) Book Translations in Greek: Three English Medical Books of Pharmacology and Physiology and three German Medical Books of Clinical Pharmacology and Therapeutics.
Research Interest: Cardiovascular diseases, Endothelial function, Hypertension, Diabetes, Renin-angiotensin-system
Research Interest: Her
Clinical and Research Interest Focuses on Diabetes Management, Cardiovascular
Risk, Flow Cytometry-Based Study of Endothelial Dysfunction, Novel Therapy for
Type 2 Diabetes, Clinical Nutrition and Mediterranean Diet
Research Interest: Dietetics
Applied to Bariatric Ssurgery; Clinical Impact of Bariatric Surgery on
Patient’s Body Composition (Fat Mass and Fat-Free Mass) and Resting Metabolic
Rate; Pre- and Post-Operative Treatment of Micronutrient Deficiencies in
Patients that Underwent Bariatric Surgery.
Research Interest: Metabolomics
Studies, Particularly on the Fetal-Neonatal Nutrition and Prevention of Chronic
Diseases in Adults such as Obesity, Diabetes and Metabolic Syndrome.
Research Interest: Clinical Cardiology; Clinical Pharmacology; Cardiovascular Physiology; Arterial Hypertension; Blood Pressure Monitoring; Telemedicine.1. Parati G, Ravogli A, Trazzi S, OMBONI S, Frattola A, Lattuada S, Libretti A, Mancia G. Balanced 24-hour blood pressure control by angiotensin-converting enzyme inhibitors administered once daily. J Hum Hypertens 1989;1:3-9.
2 Parati G, Ravogli A, Bragato R, OMBONI S, Mutti E, Mancia G. Clinical and hemodynamic effects of celiprolol in essential hypertension. J Cardiovasc Pharmacol 1989;7:S14-21.
3 Mancia G, Groppelli A, Casadei R, OMBONI S, Mutti E, Parati G. Cardiovascular effects of smoking. Clin Exp Hypertens A 1990;5:917-29.
4 Parati G, Castiglioni P, Di Rienzo M, OMBONI S, Pedotti A, Mancia G. Sequential spectral analysis of 24-hour blood pressure and pulse interval in humans. Hypertension 1990;4:414-21.
5 Groppelli A, OMBONI S, Parati G, Mancia G. Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition. J Hypertens Suppl 1990;5:S35-40.
6 Mutti E, Trazzi S, OMBONI S, Parati G, Mancia G. Effect of placebo on 24-h non-invasive ambulatory blood pressure. J Hypertens 1991;4:361-4.
7 Parati G, Trazzi S, Ravogli A, Casadei R, OMBONI S, Mancia G. Methodological problems in evaluation of cardiovascular effects of stress in humans. Hypertension 1991;4 Suppl:III50-5.
8 Groppelli A, OMBONI S, Ravogli A, Villani A, Parati G, Mancia G. Validation of the SpaceLabs 90202 and 90207 devices for ambulatory blood pressure monitoring by comparison with intra-arterial resting and ambulatory measurements. J Hypertens Suppl 1991;6:S334-5.
9 Trazzi S, OMBONI S, Mutti E, Parati G, Zanchetti A, Mancia G. Acute modulation of arterial compliance in mild essential hypertension. J Hypertens Suppl 1991;6:S110-1.
10 Zito M, Parati G, OMBONI S, Cervone C, Ulian L, D'Aviero M, Abate G, Mancia G. Effect of ageing on blood pressure variability. J Hypertens Suppl 1991;6:S328-9.
11 OMBONI S, Ravogli A, Parati G, Zanchetti A, Mancia G. Prognostic value of ambulatory blood pressure monitoring. J Hypertens Suppl 1991;3:S25-8.
12 Parati G, Groppelli A, OMBONI S, Trazzi S, Frattola A, Mancia G. Testing the accuracy of blood pressure monitoring devices in ambulatory conditions. J Hypertens Suppl 1991;8:S7-9.
13 Di Rienzo M, Parati G, Castiglioni P, OMBONI S, Ferrari AU, Ramirez AJ, Pedotti A, Mancia G. Role of sinoaortic afferents in modulating BP and pulse-interval spectral characteristics in unanesthetized cats. Am J Physiol 1991;6 Pt 2:H1811-8.
14 Groppelli A, Giorgi DM, OMBONI S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992;5:495-9.
15 Giannattasio C, Cattaneo BM, OMBONI S, Seravalle G, Bolla G, Turolo L, Morganti A, Grassi G, Zanchetti A, Mancia G. Sympathomoderating influence of benazepril in essential hypertension. J Hypertens 1992;4:373-8.
16 Mancia G, OMBONI S, Parati G, Trazzi S. Twenty-four hour blood pressure monitoring and end-organ damage. Blood Press Suppl 1992;1:38-41.
17 Mancia G, Frattola A, OMBONI S, Parati G, Rarogli A. Twenty-four-hour blood pressure and antihypertensive treatment. Blood Press Suppl 1992;1:44-5.
18 Parati G, OMBONI S, Di Rienzo M, Frattola A, Albini F, Mancia G. Twenty-four hour blood pressure variability:clinical implications. Kidney Int Suppl 1992;37:S24-8.
19 Groppelli A, OMBONI S, Parati G, Mancia G. Evaluation of noninvasive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension 1992;2:227-32.
20 Trazzi S, OMBONI S, Santucciu C, Parati G, Mancia G. Variability in arterial diameter and compliance:compliance modulation reserve. J Hypertens Suppl 1992;6:S41-3.
21 Villani A, Parati G, Groppelli A, OMBONI S, Di Rienzo M, Mancia G. Noninvasive automatic blood pressure monitoring does not attenuate nighttime hypotension. Evidence from 24 h intraarterial blood pressure monitoring. Am J Hypertens 1992;10:744-7.
22 Mancia G, OMBONI S, Ravogli A, Frattola A, Villani A. Ambulatory blood pressure monitoring. Drugs 1992;1:17-22.
23 OMBONI S, Frattola A, Parati G, Ravogli A, Mancia G. Clinical value of blood pressure measurements:focus on ambulatory blood pressures. Am J Cardiol. 1992;12:4D-8D.
24 Mancia G, OMBONI S, Parati G, Trazzi S, Mutti E. Limited reproducibility of hourly blood pressure values obtained by ambulatory blood pressure monitoring:implications for studies on antihypertensive drugs. J Hypertens 1992;12:1531-5.
25 OMBONI S, Ravogli A, Mancia G. Ambulatory blood pressure monitoring and antihypertensive treatment. J Hum Hypertens 1992;2:S9-13.
26 Mancia G, Giannattasio C, OMBONI S. Ambulatory blood pressure monitoring and antihypertensive treatment. Eur Heart J 1992;G:43-7.
27 Mancia G, De Cesaris R, Fogari R, Lattuada S, Montemurro G, Palombo C, Porcellati C, Ranieri G, Tettamanti F, Verdecchia P, Marelli C, OMBONI S, Ravogli A, Zanchetti A, for the Italian Trandolapril Study Group. Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study Group. Am J Cardiol 1992;70:60D-66D.
28 Laurent S, Hayoz D, Trazzi S, Boutouyrie P, Waeber B, OMBONI S, Brunner HR, Mancia G, Safar M. Isobaric compliance of the radial artery is increased in patients with essential hypertension. J Hypertens 1993;1:89-98.
29 Mancia G, OMBONI S, Parati G, Santucciu C, Trazzi S, Ulian L. Clinical value of ambulatory blood pressure monitoring. Am J Hypertens 1993;3 Pt 2:9S-13S.
30 Parati G, di Rienzo M, OMBONI S, Castiglioni P, Frattola A, Mancia G. Spectral analysis of 24 h blood pressure recordings. Am J Hypertens 1993;6 Pt 2:188S-193S.
31 Mancia G, OMBONI S, Parati G, Sega R, Trazzi S. Ambulatory blood pressure monitoring in the design of studies on antihypertensive drug efficacy. Am J Hypertens 1993;6 Pt 2:233S-235S.
32 OMBONI S, Parati G, Frattola A, Mutti E, Di Rienzo M, Castiglioni P, Mancia G. Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intra-arterial recordings. Hypertension. 1993;1:26-33.
Zanchetti A, Bianchi L, Amigoni S, OMBONI S, Villani A, Ravogli A. Antihypertensive effects of nifedipine gastrointestinal therapeutic system on clinic and ambulatory blood pressure in essential hypertensives. Italian GITS Study Group. J Hypertens Suppl 1993;5:S334-5.
34 Pomidossi G, Saino A, Perondi R, Gregorini L, Alessio P, Rimini A, OMBONI S, Zanchetti A, Mancia G. Impairment of the arterial baroreflex during symptomatic and silent myocardial ischemia in humans. J Am Coll Cardiol 1993;7:1866-72.
35 Ravogli A, OMBONI S, De Cesaris R, Fogari R, Lattuada S, Montemurro G, Palombo C, Porcellati C, Ranieri G, Tettamanti C. Twenty-four-hour ambulatory blood pressure monitoring and antihypertensive treatment:focus on ACE inhibitors. J Cardiovasc Pharmacol 1994;1:S15-9.
36 Mancia G, OMBONI S, Parati G, Ravogli A, Sega R, Ulian L. Ambulatory blood pressure monitoring in the diagnosis of hypertension and evaluation of antihypertensive drug efficacy. Blood Press Suppl 1994;2:20-2.
37 Mancia G, Frattola A, Groppelli A, OMBONI S, Parati G, Ulian L, Villani A. Blood pressure reduction and end-organ damage in hypertension. J Hypertens Suppl 1994;8:S35-41.
38 Parati G, Ravogli A, Mutti E, Santucciu C, OMBONI S, Mancia G. Ambulatory blood pressure monitoring in the evaluation of antihypertensive drugs. J Hypertens Suppl 1994;8:S9-15.
39 OMBONI S, Smit AA, Wieling W. Twenty four hour continuous non-invasive finger blood pressure monitoring:a novel approach to the evaluation of treatment in patients with autonomic failure. Br Heart J 1995;3:290-2.
40 Mancia G, OMBONI S, Parati G, Ravogli A, Villani A, Zanchetti A. Lack of placebo effect on ambulatory blood pressure. Am J Hypertens 1995;3:311-5.
41 Mancia G, OMBONI S, Ravogli A, Parati G, Zanchetti A. Ambulatory blood pressure monitoring in the evaluation of antihypertensive treatment:additional information from a large data base. Blood Press 1995;3:148-56.
42 Parati G, Di Rienzo M, OMBONI S, Ulian L, Mancia G. Blood pressure variability over 24 hours:its different components and its relationship to the arterial baroreflex. J Sleep Res 1995;S1:21-29.
43 Mancia G, Giannattasio C, Turrini D, Grassi G, OMBONI S. Structural cardiovascular alterations and blood pressure variability in human hypertension. J Hypertens Suppl 1995;2:S7-14.
44 OMBONI S, Parati G, Zanchetti A, Mancia G. Calculation of trough:peak ratio of antihypertensive treatment from ambulatory blood pressure:methodological aspects. J Hypertens 1995;10:1105-12.
45 OMBONI S, Ravogli A, Villani A, Mancia G. Permanent blood pressure control over the 24 h by trandolapril. Am J Hypertens 1995;10 Pt 2:71S-74S.
46 Thijs L, Dabrowska E, Clement D, Fagard R, Laks T, Mancia G, O'Brien E, OMBONI S, Parati G, Staessen J, et al. Diurnal blood pressure profile in older patients with isolated systolic hypertension. The SYST-EUR Investigators. J Hum Hypertens 1995;11:917-24.
47 Parati G, Ulian L, Santucciu C, OMBONI S, Mancia G. Blood pressure variability, cardiovascular risk and antihypertensive treatment. J Hypertens Suppl 1995;4:S27-34.
48 Ravogli A, Arzilli F, OMBONI S, Giovannetti R, Mutti E, Salvetti A, Mancia G. Lack of effect of percutaneous transluminal renal angioplasty on nocturnal hypotension in renovascular hypertensive patients. J Hypertens 1996;1:53-6.
49 Parati G, Frattola A, OMBONI S, Mancia G, Di Rienzo M. Analysis of heart rate and blood pressure variability in the assessment of autonomic regulation in arterial hypertension. Clin Sci (Lond) 1996;91 Suppl:129-32.
50 Mancia G, Parati G, OMBONI S, Ravogli A, Villani A, Santucciu C, Ulian L. Ambulatory blood pressure monitoring in the ELSA study. European Lacidipine Study on Atherosclerosis. Blood Press Suppl 1996;4:36-8.
51 Mancia G, OMBONI S. Ambulatory blood pressure, blood pressure variability and antihypertensive treatment. Clin Exp Hypertens. 1996;3-4:449-62.
52 Mancia G, OMBONI S, Parati G. Lessons to be learned from 24-hour ambulatory blood pressure monitoring. Kidney Int Suppl 1996;55:S63-8.
53 Parati G, OMBONI S, Mancia G. Difference between office and ambulatory blood pressure and response to antihypertensive treatment. J Hypertens. 1996;6:791-7.
54 OMBONI S, Parati G, Di Rienzo M, Wieling W, Mancia G. Blood pressure and heart rate variability in autonomic disorders:a critical review. Clin Auton Res 1996;3:171-82.
55 Mancia G, Gamba PL, OMBONI S, Paleari F, Parati G, Sega R, Zanchetti A. Ambulatory blood pressure monitoring. J Hypertens Suppl 1996;2:S61-6;discussion S66-8.
56 OMBONI S, Parati G, Groppelli A, Ulian L, Mancia G. Performance of the AM-5600 blood pressure monitor:comparison with ambulatory intra-arterial pressure. J Appl Physiol 1997;2:698-703.
57 Mancia G, OMBONI S, Parati G. Assessment of antihypertensive treatment by ambulatory blood pressure. J Hypertens Suppl 1997;2:S43-50.
58 Mancia G, OMBONI S, Grassi G. Combination treatment in hypertension:the VeraTran Study. Am J Hypertens 1997;7 Pt 2:153S-158S.
59 Zanchetti A, OMBONI S, Di Biagio C. Candesartan cilexetil and enalapril are of equivalent efficacy in patients with mild to moderate hypertension. J Hum Hypertens 1997;2:S57-9.
60 Baccelli G, Reggiani P, Mattioli A, Corbellini E, Garducci S, Catalano M, OMBONI S. Hemodynamic changes in the lower limbs during treadmill walking in normal subjects and in patients with arteriosclerosis obliterans. Angiology 1997;9:795-803.
61 Santucciu C, Parati G, Ulian L, OMBONI S, Mancia G. [The difference between clinical ambulatory measured blood pressure and daily monitored pressure does not reflect the "white coat effect"]. Cardiologia 1997;10:1067-9.
62 Parati G, OMBONI S, Staessen J, Thijs L, Fagard R, Ulian L, Mancia G. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators. J Hypertens 1998;1:23-9.
63 Mancia G, OMBONI S, Zanchetti A. Clinical advantages of lipophilic dihydropyridines. Blood Press Suppl. 1998;2:23-6.
64 Parati G, Ulian L, Santucciu C, OMBONI S, Mancia G. Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 1998;5:1185-9.
65 OMBONI S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, Mancia G. Reproducibility and clinical value of nocturnal hypotension:prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens 1998;6:733-8.
OMBONI S, Parati G, Mancia G. The trough:peak ratio and the smoothness index in the evaluation of control of 24 h blood pressure by treatment in hypertension. Blood Press Monit 1998;3:201-204.
67 OMBONI S, Parati G, Castiglioni P, Di Rienzo M, Imholz BP, Langewouters GJ, Wesseling KH, Mancia G. Estimation of blood pressure variability from 24-hour ambulatory finger blood pressure. Hypertension 1998;1:52-8.
68 OMBONI S, Fogari R, Palatini P, Rappelli A, Mancia G. Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect:evidence from the sample study. Hypertension 1998;3:424-9.
69 Mancia G, Cattaneo BM, OMBONI S, Grassi G. Clinical benefits of a consistent reduction in blood pressure. J Hypertens Suppl 1998;6:S35-9.
70 Parati G, OMBONI S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index:a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens 1998;11:1685-91.
71 OMBONI S, Zanchetti A. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators. J Hypertens 1998;12 Pt 1:1831-8.
72 Mancia G, Parati G, OMBONI S, Ulian L, Zanchetti A. Ambulatory blood pressure monitoring. Clin Exp Hypertens 1999;5-6:703-15.
73 Castiglioni P, Parati G, OMBONI S, Mancia G, Imholz BP, Wesseling KH, Di Rienzo M. Broad-band spectral analysis of 24 h continuous finger blood pressure:comparison with intra-arterial recordings. Clin Sci (Lond) 1999;2:129-39.
74 OMBONI S, Parati G, Mancia G. [Monitoring of blood pressure for 24 hours:historical, technical, and methodological features]. Cardiologia 1999;1(Pt 2):997-1000.
75 Parati G, OMBONI S, Mancia G. [Trough-peak ratio and the smoothness index in the assessment of duration and homogeneity of 24-hour antihypertensive effect]. Cardiologia 1999;1(Pt 1):345-8.
76 Mancia G, OMBONI S, Parati G. The importance of blood pressure variability in hypertension. Blood Press Monit 2000;1:S9-S15.
77 Mancia G, OMBONI S, Agabiti-Rosei E, Casati R, Fogari R, Leonetti G, Montemurro G, Nami R, Pessina AC, Pirrelli A, Zanchetti A. Antihypertensive efficacy of manidipine and enalapril in hypertensive diabetic patients. J Cardiovasc Pharmacol 2000;6:926-31.
78 OMBONI S, Fogari R, Mancia G. A smooth blood pressure control is obtained over 24 h by delapril in mild to moderate essential hypertensives. Blood Press 2001;3:170-5.
79 Zanchetti A, OMBONI S. Comparison of candesartan versus enalapril in essential hypertension. Italian Candesartan Study Group. Am J Hypertens 2001;2:129-34.
80 Parati G, OMBONI S, Villani A, Glavina F, Castiglioni P, Di Rienzo M, Mancia G. Reproducibility of beat-by-beat blood pressure and heart rate variability. Blood Press Monit 2001;4:217-20.
81 Mancia G, OMBONI S, Parati G, Clement DL, Haley WE, Rahman SN, Hoogma RP. Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study. J Hypertens 2001;10:1755-63.
82 Zanchetti A, OMBONI S, La Commare P, De Cesaris R, Palatini P. Efficacy, tolerability, and impact on quality of life of long-term treatment with manidipine or amlodipine in patients with essential hypertension. J Cardiovasc Pharmacol 2001;4:642-50.
83 Mancia G, Parati G, Hennig M, Flatau B, OMBONI S, Glavina F, Costa B, Scherz R, Bond G, Zanchetti A;ELSA Investigators. Relation between blood pressure variability and carotid artery damage in hypertension:baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2001;11:1981-9.
84 OMBONI S, Smit AA, van Lieshout JJ, Settels JJ, Langewouters GJ, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure. Clin Sci (Lond) 2001;6:609-18.
85 Antonicelli R, OMBONI S, Giovanni DC, Ansuini R, Mori A, Gesuita R, Parati G, Paciaroni E. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring. Drugs Aging 2002;7:541-51.
86 Porcellati C, OMBONI S. Switching from ACE inhibitors, beta-blockers, calcium antagonists or diuretics to candesartan improves efficacy and tolerability. Blood Press 2002;5:310-9.
87 Mancia G, OMBONI S, Parati G;Investigators of the INSIGHT ABPM substudy. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT). J Hypertens 2002;3:545-53.
88 Taddei S, OMBONI S, Ghiadoni L, Caiazza A, Fogari R, Innocenti P, Porcellati C, Giovannetti R, Corradi L, Mancia G, Salvetti A. Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients. J Cardiovasc Pharmacol 2003;4:579-85.
89 Mancia G, OMBONI S;CARDIO (CAndesaRtan combined with DIuretic in hypertensiOn) Study Group. Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients. Blood Press Suppl 2004;2:11-7.
90 Malacco E, Piazza S, OMBONI S;on behalf of the Zofenopril Study Group. Zofenopril versus Lisinopril in the Treatment of Essential Hypertension in Elderly Patients: A Randomised, Double-Blind, Multicentre Study. Clin Drug Investig 2005;3:175-182.
91 Mancia G, Parati G, Bilo G, Maronati A, OMBONI S, Baurecht H, Hennig M, Zanchetti A. Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure:data from the European Lacidipine Study on Atherosclerosis. J Hypertens 2007;5:1087-94.
92 Orzalesi N, Rossetti L, OMBONI S;OPTIME Study Group (Osservatorio sulla Patologia glaucomatosa, Indagine Medico Epidemiologica);CONPROSO (Collegio Nazionale dei Professori Ordinari di Scienze Oftalmologiche). Vascular risk factors in glaucoma:the results of a national survey. Graefes Arch Clin Exp Ophthalmol 2007;6:795-802.
93 Pini C, Pastori M, Baccheschi J, OMBONI S, Parati G;European Society of Hypertension. Validation of the Artsana CSI 610 automated blood pressure monitor in adults according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007;3:179-84.
94 Bussone G, Tullo V, d'Onofrio F, Petretta V, Curone M, Frediani F, Tonini C, OMBONI S. Frovatriptan for the prevention of postdural puncture headache. Cephalalgia 2007;7:809-13.
95 OMBONI S, Riva I, Giglio A, Caldara G, Groppelli A, Parati G. Validation of the Omron M5-I, R5-I and HEM-907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007;4:233-42.
96. Malacco E, OMBONI S. Antihypertensive efficacy of zofenopril plus hydrochlorothiazide fixed combination for treatment in metabolic syndrome. Adv Ther 2007;5:1006-15.
97 Pecori Giraldi F, Toja PM, De Martin M, Maronati A, Scacchi M, OMBONI S,Cavagnini F, Parati G. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure. Horm Metab Res 2007;12:908-14.
98 Pini C, Natalizi A, Gerosa PF, Frigerio M, OMBONI S, Parati G. Validation of the Artsana CS 410 automated blood pressure monitor in adults according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2008;13:177-182.
99 OMBONI S, Costantini C, Pini C, Bulegato R, Manfellotto D, Rizzoni D, Palatini P, O'brien E, Parati G. PA.NET International Quality Certification Protocol for blood pressure monitors. Blood Press Monit 2008;13:285-289.
100 Parati G, OMBONI S, Palatini P, Rizzoni D, Bilo G, Valentini M, Agabiti-Rosei E, Mancia G. Italian Society of Hypertension Guidelines for Conventional and Automated Blood Pressure Measurement in the Office, at Home and Over 24 Hours. High Blood Pressure & Cardiovascular Prevention 2008;15:283-310.
Research Interest: Rehabilitation,
Working with Older People, Diabetes, Stroke Care, Research
Dr. Gorelik has nearly 35 years of experience in clinical medicine and research. He has published more than 60 scientific publications. Currently, Dr. Gorelik serves as the Head of the Department of Internal Medicine "F" in the Assaf Harofeh Medical Center, Zerifin, Israel. He is also a Clinical Senior Lecturer in the Sackler Faculty of Medicine of the Tel Aviv University.
Research Interest: Diabetes,
Orthostatic Hypotension, Magnesium Metabolism, Heart Failure and Hospital
Number of Publications: 57
Research Interest: Epidemiology
of Diabetes; Mechanism of Insulin Action; Insulin Resistance; Obesity and
Insulin Resistance; Cardiovascular Risk Diabetes and Obesity; Bone Metabolism and
Diabetes and Obesity; Gene Adiposities Tissue in Diabetes and Obesity.
Research Interest: Diabetes;
Metabolic Syndrome; Osteoporosis
Research Interest: Deep Specialization
in Research Involve; Obesity and Associated Disorder, Its Mechanism and
Treatment. Metabolic Syndrome-Food Additives and Its Effect on the Bodyorgans. Also
the Biochemical, Oxidative Stress and Advanced Biomarkers in Health and
Diseases. Recently Involved in Nanomedical Materials as Antioxidant for Health
Research Interest: Integrated
Pharmaco-Physiology, Brain-Gut Interactions, Stress-Related Functional
Gastrointestinal Diseases, Ingestive Behavior-Associated Gastrointestinal
Neuroendocrinology, and Bariatric Surgery
Research Interest: Liver Cirrhosis, Gastrointestinal Diseases, Liver, Hepatitis, Chronic Hepatitis C, Cirrhosis, Bacteria, Virulence Factors, Cells
Research Interest: Evaluation of biological activity of plant foods: anti-inflammatory, anti-glycation, anti-oxidant activities Influences of heat treatment on biological activity of foods.
List of Publications:
1. Ho, Su-Chen, Chang, Yi-Huang, “Comparison of inhibitory capacities of 6-, 8- and 10-gingerols/shogaols on the canonical NLRP3 inflammasome-mediated IL-1β secretion” Molecules, Vol. 23, 2018, 02, p. 466.
2. Ho, Su-Chen, Su, Min-Sheng, Lin, Chih- Cheng, Chiu, Chui-Feng, “Comparison of anti-glycation capacity of two new purple-colored-leaf tea cultivars with an ordinary green-colored-leaf tea cultivar in Taiwan,” Global Journal of Obesity, Diabetes and Metabolic Syndrome, Vol. 4, No. 1, 2017, 02, pp. 009-015.
3. Yang, Tzu-Ting, Ho, Su-Chen, Chuang, Lu-Te, Chuang, Hsiao-Chi, Li, Ya-Ting, Wu, Jyun-Jie, “Characterization of particulate-phase polycyclic aromatic hydrocarbons emitted from incense burning and their bioreactivity in RAW264.7 macrophage,” Environmental Pollution, Vol. 220, 2017, 01, pp. 1190-1198.
4. Ho, Su-Chen, Su, Min-Sheng, “Optimized heat treatment enhances the anti-inflammatory capacity of ginger “ International Journal of Food Properties, Vol. 19, 2016, pp. 1884-1898.
5. Ho, Su-Chen, Su, Min-Sheng, “Evaluating the anti-neuroinflammatory capacity of raw and steamed garlic as well as five organosulfur compounds,” Molecules, Vol. 19, No. 11, 2014, pp. 17697-17714.
6. Ho, Su-Chen, Kuo, Chun-Ting, “Hesperidin, Nobiletin, and Tangeretin Are Collectively Responsible for the Anti-neuroinflammatory Capacity of Tangerine Peel (Citri reticulatae pericarpium)” Food and Chemical Toxicology, Vol. 71, 2014, pp. 176-182.
7. Ho, Su-Chen, Chang, Pei-Wen, Tong, Hui-Ting, Yu, Pin-Yuan, “Inhibition of Fluorescent Advanced Glycation End-products and N-carboxymethyllysine Formation by Several Floral Herbal Infusions,” International Journal of Food Properties, Vol. 17, 2014, pp. 617-628.
8. Ho, Su-Chen, Su, Min-Sheng, Lin, Chih-Cheng, “Comparison of Peroxynitrite-Scavenging Capacities of Several Citrus Fruit Peels,” International Journal of Food Properties, Vol. 17, 2014, pp. 111-124.
9. Ho, Su-Chen, Chang, Ku-Shang, Lin, Chih-Cheng, “Anti-neuroinflammatory Capacity of Fresh Ginger Is Attributed Mainly to 10-Gingerol,” Food Chemistry, Vol. 141, No. 3, 2013, 12, pp. 3183-3191.
10. Ho, Su-Chen, Chang, Ku-Shang, Chang, Pei-Wen, “Inhibition of Neuroinflammation by Cinnamon and its Main Components,” Food Chemistry, Vol. 138, No. 4, 2013, pp. 2275-2282.
11. Ho, Su-Chen, Chang, Pei-Wen, “Inhibitory Effects of Several Spices on Inflammation Caused by Advanced Glycation Endproducts,” American Journal of Plant Sciences, Vol. 3, No. 7, 2012, pp. 995-1002.
12. Ho, Su-Chen, Wu, Szu-Pei, Lin, Shyh-Mirn, Tang, Ya-Li, “Comparison of Anti-glycation Capacities of Several Herbal Infusions with that of Green Tea,” Food Chemistry, Vol. 122, 2010, pp. 768-744.
13. Lin, Shih-Min, Wang, Shih-Wei, Ho, Su-Chen, Tang, Ya-Li, “Protective Effect of Green Tea (-)-Epigallocatechin-3-gallate (EGCG) Against the Monoamine Oxidase B Enzyme Activity Increase in Adult Rat Brains,” Nutrition, Vol. 26, 2010, pp. 1195-1200.
14. Huang, Yung-Sheng, Ho, Su-Chen, “Polymethoxy Flavones Are Responsible for the Anti-inflammatory Activity of Citrus Fruit Peel,”Food Chemistry, Vol. 119, 2010, pp. 868-873.
15. Ho, Su-Chen, Tang, Ya-Li, Lin, Shih-Min, Liew, Yih-Fong, “Evaluation of Peroxynitrite-Scavenging Capacities of Several Commonly Used Fresh Spices,” Food Chemistry, Vol. 119, 2010, pp. 1102-1107.
16. Ho, Su-Chen, Lin, Chih-Cheng, “Investigation of Heat Treating Conditions for Enhancing the Anti-inflammatory Activity of Citrus Fruit (Citrus reticulata) Peels,”Journal of Agricultural and Food Chemistry, Vol. 56, 2008, pp. 7976-7982.
17. Lin, Chih-Cheng, Hung, Pi-Fong, Ho, Su-Chen, “Heat Treatment Enhances the NO-suppressing and Peroxynitrite-intercepting Activities of Kumquat’s (Fortunella margarita Swingle) Peel,”Food Chemistry, Vol. 109, 2008, pp. 95-103.
18. Ho, Su-Chen, Tsai, Tzung-Hsun, Tsai, Po-Jung, Lin, Chih-Cheng, “Protective Capacities of Certain Spices Against Peroxynitrite-mediated Biomolecular Damage,”Food and Chemical Toxicology, Vol. 46, 2008, pp. 920-928.
19. Ho, Su-Chen, Hwang, Lucy Sun, Shen, Yi-Jane, Lin, Chih-Cheng, “Suppressive Effect of a Proanthocyanidin-rich Extract from Longan (Dimocarpus longan Lour.) Flowers on Nitric Oxide Production in LPS-Stimulated Macrophage Cells,”Journal of Agricultural and Food Chemistry, Vol. 55, No. 26, 2007, pp. 10664-10670.
20. Tsai, Po-Jung, Tsai, Tzung-Hsun, Ho, Su-Chen, “In vitro Inhibitory Effects of Rosemary Extracts on Growth and Glucosyltransferase Activity of Streptococcus sobrinus,” Food Chemistry, Vol. 105, 2007, pp. 311-316.
21. Tsai, Po-Jung, Tsai, Tzung-Hsun, Yu, Chun-Hsien, Ho, Su-Chen, “Evaluation of NO-suppressing Activity of Several Mediterranean Culinary Spices,” Food and Chemical Toxicology, Vol. 45, 2007, pp. 440-447.
22. Tsai, Po-Jung, Tsai, Tzung-Hsun, Yu, Chun-Hsien, Ho, Su-Chen, “Comparison of NO-scavenging and NO-suppressing Activities of Different Herbal Teas with those of Green Tea,” Food Chemistry, Vol. 103, 2007, pp. 181-187.
23. Lin, Chih-Cheng, Lu, Min-Jer, Chen, Shen-Jen, Ho, Su-Chen, “Heavy Fermentation Impacts NO-Suppressing Activity of Tea in LPS-activated RAW 264.7 Macrophages,” Food Chemistry, Vol. 98, 2006, pp. 483-489.
24. Tsai, Tzung-Hsun, Tsai, Po-Jung, Ho, Su-Chen, “Antioxidant and Antiinflammatory Activities of Several Commonly Used Spices,” Journal of Food Science, Vol. 70, No. 1, 2005, pp. pp. C93-C97.
25. Tsai, Po-Jung, Yu, Chun-Hsien, Hsu SP, Lee YH, Huang IT, Ho, Su-Chen, Chu CH “Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: Negative association with gestational diabetes mellitus” Nutrition, Vol. 21, No. 11-12, 2005, pp.1095-9 •
26. Tsai, Po-Jung, Ho, Su-Chen, Tsai LP, Lee YH, Hsu SP, Yang SP, Chu CH, Yu, Chun-Hsien, “Lack of relationship between beta3-adrenergic receptor gene polymorphism and gestational diabetes mellitus in a Taiwanese population” Metabolism, Vol. 53, No. 9, 2004, pp.1136-9.
27. Tsai, Po-Jung, Yu, Chun-Hsien, Hsu SP, Lee YH, Chiou CH, Hsu YW, Ho, Su-Chen, Chu CH. “Cord plasma concentrations of adiponectin and leptin in healthy term neonates: positive correlation with birthweight and neonatal adiposity” Clin. Endocrinol. Vol. 61, 2004, pp. 88-93.
28. Ho, Su-Chen, Tsai, Po-Jung, ”Comparison of the effects of "hot" and "cold" Chinese medicinal plants on the production of inflammatory mediators by RAW 264.7 cells” Journal of Food and Drug Analysis, Vol. 12, No. 2, 2004, pp. 120-127.
Research Interest: Medicinal Herbs, Behavioral
Pharmacology, Neurodegeneration, Neurotransmitters, Neuroscience, Diabetes, Inflammation
Research Interest: Kidney transplantation, glomerular disease and pathological basics of the diseases
Research Interest: Own
Publications in Different Areas of Health, among them Obesity and Metabolic
Syndrome which is a Major Focus of Interest, Pricipalmente when Combined with
Research Interest: Has Experience in Physical Therapy, with an
Emphasis on Cardiopulmonary Physical Therapy, Acting on the Following Topics: Health
Promotion, Cardiac Rehabilitation, Exercise Prescription for People with Special
Needs, Assessment of Autonomic Function, Analysis of Biological Signals, Cardiorespiratory
Physiotherapy in Morbid Obesity and Physical Therapy in Intensive Care.
Research Interest: Obesity, Mind and Inhibitory Control, Metabolic
Syndrome, Rationale, Cardiovascular Disease
Research Interest: He Also Conducted Basic Research in
Regard to the Investigation of the Role of Immunological Aspects in Kidney
Diseases Including Nephritic Syndrome and Diabetic Nephropathy.
Research Interest: Area of Gastrointestinal Cancer and
Inflammatory Bowel Disease.
China Diabetes Impact Study is funded by IDF and technically supported by Division of Diabetes Translation of CDC. It is a follow-up study of China National Diabetes and Metabolic Disorder Study. A total of 12 study sites participated in the China Diabetes Impact Study. I am the national program coordinator and the investigator of Beijing study site. All study participants with DM, NDM and IGR were interviewed and collected information about their health care service use, medical expenditure, etc.
Research Interest: Directed Toward the Idenfication of
Bioactive Compound, the Total Synthesis, and Structural Modification of Natural
Products from Chinese Herds, Drug Design and Synthesis Based on Natural Lead
Compounds, Mechanism Study of Natural Products, Peptide Investigation Initiated
from Natural Resources, the Interface of Organic Chemistry and Cell Biology.
Research Interest: Metabolic and Bariatric Surgery,
Gastrointestinal Surgery, Thyroid Surgery, Hepatobiliary Surgery, Hernia
Surgery, Anorectal Surgery, General Surgery.
Research Interest: Molecular Pharmacology, Chinese Medicines and Diabetes
Mellitus, Effects and Mechanism of Natural Products on Cardio-Cerebrovascular
Research Interest: Internal Medicine and Cardiology
Research Interest: Application of
Multiple Linear and Logistic Regression Models, Applied Longitudinal Data
Analysis, Generalized Linear and Non-Linear Mixed Models, and Survival
Analysis; Epidemiology of Chronic Diseases Including Alcohol use Disorders and
Drug Abuse, Alzheimer’s Disease, Cancer, Obesity and Diabetes, Heart Disease and
Stroke; Genetic Epidemiology of Complex Diseases Including Alcohol Dependence
And Comorbidity, Obesity, Diabetes and Related Conditions, Depression and
Research Interest: Nutrition,
Weight management, Obesity Evaluation, Behavior Change Interventions, Critical
Thinking, Health Disparity, Curriculum and Program Development, Type 2 Diabetes
Dr. Mehta’s research program focuses on the role of innate immunity and inflammation in the development of cardiovascular and metabolic diseases. Using a trans-disciplinary approach that involves genetic epidemiology, translational medicine, and novel cardiovascular imaging approaches, Dr. Mehta and his team study how inflammation affects insulin resistance, the development of metabolic syndrome, and lipoprotein dysfunction, all of which are risk factors for atherosclerosis and subsequent cardiovascular disease (CVD).
Research Interest: Obesity,
Chronic Hronic Inflammation, Inflammatory Disease, Cancer
Research Interest: Nutrition,
Obesity, Weight, Diet
Research Interest: Cardiovascular
Disease, Electrophysiology, Pacemaker, ICD and CRT Therapy, Metabolic Syndrome,
Bidirectional Effect of CVD and CKD
Research Interest: Epidemiology, pathogenesis, diagnosis and treatment of fatty liver (metabolic and viral); genetic determinants of fatty liver; metabolic syndrome; insulin resistance; association between fatty liver, metabolic syndrome, diabetes and cardiovascular diseases; liver ultrasonography.
Research Interest: It
is Mainly Lies in Two Areas. First I Focused on Applying Statistical Methods and
Multilevel Modeling in Randomized Clinical Trials and Family-Based
Health-Related Interventions, Particularly in Substance Abuse, HIV/AIDS, STD,
Sexual Risk Behaviors and Minority Health Disparities. Second, I am Interested in
Epidemiology Studies 0f Chronic Disease Including Alcohol Use Disorder, Drug Abuse,
Obesity, Diabetes, Metabolic Syndrome, Hypertension, Cardiovascular Disease and
Stroke; and Also from Genetic Epidemiology Point of View to Examine Complex
Disease Including Alcohol Dependence and Co-Morbidity, and Alzheimer Disease
Research Interest: My
Research Interests Span Many Areas Including Bioinformatics and Metabolomics. As
a Phd Student at Center of Magnetic Resonance of University of Florence (Italy),
My Research Focused on the Metabolomic Analysis of Biofluid (E.G., Urine,
Serum, Saliva) and Tissue (E.G., Intact Human Liver) Samples. I Used Nuclear
Magnetic Resonance (NMR) Spectroscopy and Advanced Statistical Analysis
Techniques to Identify and Predict Metabolomic Fingerprints. In Particular, I Used
NMR-Based Metabolomic Analysis to Identify a Fingerprint of Poor-Survival in the
Serum of Patient with Metastatic Colorectal Cancer.
Now as Postdoc at Dana-Farber Cancer Institute, My Current Research Focuses on Identifying Metabolic Fingerprint Predictors of Prostate Cancer Development and Progression to Improve our Understanding of The Mechanisms Linking Metabolism with the Biology of Prostate Cancer. Moreover, I Will Contribute on Developing of New Standard Operation Procedures for Metabolomic Analysis in Formalin Fixed Paraffin Embedded Tissues.
Research Interest: Multicenter
Prospective Observational CREST Study (U.Penn, Vanderbilt, and University
Hospitals Case Medical Center) with Dr. James Fang, Evaluating Cardiotoxicity of
Sunitinib in Metastatic Renal Cell Carcinoma Using Tonometry Data
Research Interest: A
Biomedical Researcher with a Focus on Neurobehavioral, Metabolic and Endocrine
Research Interest: He has Vast Experience
in Characterization of New Chemical Entities (NCE’S) for Early Stage Dosage form
Development, Preparation of Nano Particles, Spray Dried Powders, Solubility
Screening, Bio-Availability Enhancement, Granulation and Fluid Bed Drying, Compression
Using Rotary Tablet Press, Coating, Stability Studies and Tech Transfer Etc.
Research Interest: Blood Brain
Barrier; Neurovascular Pharmacokinetics; Stroke; Ischemia; Neurodegneration; Neuroprotection;
Neuropharmacology; Nutrient and Ion Transporters; Diabetes
Research Interest: My Research has
Focused on Understanding the BBB, Changes that Occur in the Blood-Tumor-Barrier
(BTB), and Drug Uptake Therein. To this End, I Have Worked and Gained
Significant Amount of Knowledge on Factors Influencing Anticancer Delivery and
Activity in Brain aBrain Metastases Developed from Breast Cancer in Mouse
Models. These Include: (1) How BBB is Altered in Mouse Models of Brain
Metastases of Breast Cancer. (2) Pharmacokinetic-Pharmacodynamic Relationship of
Anticancer Drugs in Brain Metastases. (3) in Vitro- In Vivo Correlations (IVIVC)
to Predict Optimum Therapeutic Concentrations for Treatment of Brain
Metastases. (4) Improving Targeted Anticancer Drug Delivery to Brain Tumors by
Inhibiting Efflux Transporters and Piggy Backing Drugs to Substrates of Influx
Transporters at the BBB.
Research Interest: Immunology
such as Autoimmune Diabetes (Type 1).
Dr. Rath Research Institute
1260 Memorex Drive, Santa Clara, USA
Global Journal of Cancer Therapy
Sassari University, Italy
Archive of Urological Research
University of Athens, Greece
Journal of Novel Physiotherapy and Physical Rehabilitation
California South University, USA
Open Journal of Analytical and Bioanalytical Chemistry
Peter Lloyd Nara
Private Compnay- Biological Mimetics, Inc., USA
Annals of Antivirals and Antiretrovirals
University of Athens, Greece
Open Journal of Chemistry
Huazong University of Science and Technology, China
Open Journal of Pediatrics and Child Health
Ohio State University, USA
Open Journal of Bioinformatics and Biostatistics
University of Pisa, Italy
Annals of Psychiatry and Treatment
University of Parma, Italy
International Journal of Dermatology and Clinical Research